Mitsubishi UFJ Asset Management Co. Ltd. Buys Shares of 1,548,774 Danaher Corporation $DHR

Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,548,774 shares of the conglomerate’s stock, valued at approximately $295,010,000.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the stock. State Street Corp grew its stake in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after buying an additional 472,608 shares during the last quarter. Capital International Investors lifted its stake in shares of Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after acquiring an additional 1,487,768 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in shares of Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after acquiring an additional 1,334,221 shares in the last quarter. Wellington Management Group LLP grew its position in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares during the last quarter. Finally, Norges Bank acquired a new position in Danaher in the 4th quarter worth about $2,177,106,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on DHR. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Jefferies Financial Group reiterated a “buy” rating and issued a $245.00 price objective on shares of Danaher in a report on Tuesday, April 21st. Stifel Nicolaus reduced their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Guggenheim decreased their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, Morgan Stanley dropped their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Price Performance

Danaher stock opened at $202.44 on Tuesday. The stock’s 50 day moving average is $193.52 and its 200 day moving average is $192.67. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The firm has a market cap of $142.31 billion, a P/E ratio of 35.96, a P/E/G ratio of 2.52 and a beta of 0.78. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the prior year, the firm posted $0.77 EPS. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. As a group, research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.